Community Oncology Alliance Calls for Greater Federal Action and Greater Transparency in Hospital Drug Pricing Following New Analysis
The Community Oncology Alliance (COA) is highlighting the findings of a new report which shows extreme variation and inconsistencies in drug pricing across hospital settings and insurer plans.
